Dr. Daniel S. Berman[email protected]Nuclear MedicineScreening for CAD in diabetics: Which patient? Which test?Screening for coronary artery disease (CAD) in any population is controversial. In this editorial opinion, Dr. Daniel Berman of Cedars-Sinai Medical Center points out what he believes are shortcomings in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study published this week in the Journal of the American Medical Association.April 16, 2009Page 1 of 1Top StoriesMRIStudy reports low NSF rates following GBCA administrationNephrogenic systemic fibrosis (NSF) following gadolinium-based contrast agent (GBCA) use is rare, researchers have reported.UltrasoundCEUS finds residual liver cancer after downstaging therapyPractice ManagementVenture capital investment rising in radiologyRadiation Oncology/TherapyProton therapy effective for patients with oropharyngeal cancerWomens ImagingSBI: WISDOM trial is 'contaminated and underpowered'